Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods

Vaxxas Chair Sarah Meibusch said, "The TGA manufacturing licence marks a significant milestone for Vaxxas as we progress toward commercialising our HD-MAP technology. By reducing cold-chain ...
technologynetworks

Thermo Fisher Scientific Launches Next-Generation Microarray Solution

Thermo Fisher Scientific has introduced the Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer, designed for fast and scalable sample analysis. In conjunction with two new arrays – the Applied ...
GEN

Efficiency, Sustainability Drive Thermo Fisher’s New Microarray Data Analysis Solution

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...
Hosted on MSN

Microarray platform could help predict immune‐mediated drug‐induced liver injury

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that could help predict which drugs ...
EurekAlert!

Microarray analysis of differential expression of long non-coding RNAs in peripheral blood mononuclear cells in luminal a breast cancer

In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers. This study aimed to ...
Yahoo Finance

Bionano Announces Upgrades to its Software and Compute Platforms to Make Analysis of OGM, Microarray and NGS Data Easier, Faster and More Accurate

SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced the release of the latest versions of its VIA™ and Solve™ software for genomic data analysis and ...
EurekAlert!

Emory University and Micron Biomedical launch first-in-human clinical trial of next-generation rotavirus vaccine delivered via dissolvable microarray technology

Atlanta (June 16 2025)-- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray technology, is now ...